What is she best known for?
The fields of study she is best known for:
Virology, Antibody, Epitope, Neutralizing antibody and Ebolavirus are her primary areas of study.
Her Virology research incorporates elements of HIV Envelope Protein gp41 and Protein structure.
Her Antibody research is classified as research in Immunology.
The Epitope study combines topics in areas such as Viral envelope, Peptide sequence, Monoclonal antibody and Binding site.
Her work deals with themes such as Lipid bilayer fusion, Antigen, Glycoprotein and Severe acute respiratory syndrome coronavirus 2, which intersect with Neutralizing antibody.
Her Ebolavirus study necessitates a more in-depth grasp of Ebola virus.
Her most cited work include:
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. (1255 citations)
- Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. (759 citations)
- Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. (756 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Virology, Ebola virus, Antibody, Ebolavirus and Epitope.
Her Virology study integrates concerns from other disciplines, such as Monoclonal antibody and Glycoprotein.
Her Ebola virus research is multidisciplinary, relying on both Viral life cycle, Viral protein and Cell biology.
Her studies deal with areas such as Immune system and Antigen as well as Antibody.
Her Ebolavirus research includes themes of Protein structure, Interferon and Plasma protein binding.
Her Epitope study incorporates themes from Molecular biology and Binding site.
She most often published in these fields:
- Virology (77.13%)
- Ebola virus (45.21%)
- Antibody (40.96%)
What were the highlights of her more recent work (between 2018-2021)?
- Virology (77.13%)
- Antibody (40.96%)
- Ebola virus (45.21%)
In recent papers she was focusing on the following fields of study:
Erica Ollmann Saphire mainly investigates Virology, Antibody, Ebola virus, Severe acute respiratory syndrome coronavirus 2 and Virus.
Her Virology research integrates issues from Epitope, Genome and Germline.
The concepts of her Antibody study are interwoven with issues in Immune system, Immunity, Antigen, Glycoprotein and Effector functions.
Her research in Ebola virus intersects with topics in Nucleoprotein, Neutralizing antibody, Monoclonal antibody and Cell biology.
Her research integrates issues of CD8 and Immunology in her study of Severe acute respiratory syndrome coronavirus 2.
Erica Ollmann Saphire combines subjects such as RNA and Genetic variation with her study of Virus.
Between 2018 and 2021, her most popular works were:
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. (1255 citations)
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. (268 citations)
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. (268 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Antibody, CD8, Severe acute respiratory syndrome coronavirus 2, Virology and Immunological memory.
Her study looks at the relationship between Virology and topics such as Epitope, which overlap with Monoclonal antibody.
Her work in Immunological memory covers topics such as Memory B cell which are related to areas like Immunoglobulin G.
Her Immunology study combines topics in areas such as Disease and Coronavirus disease 2019.
Erica Ollmann Saphire interconnects Genetic variation and Betacoronavirus in the investigation of issues within Virus.
She studies Ebolavirus, a branch of Ebola virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
